Registration 333-290393
S-1/A · 2026-02-02 · 0001213900-26-010410
Terms from the governing filing for this registration; not a claim that the offering is open today.
Company research
CIK 2046638Updated Nov 16, 2026
6 filings on record · FWP, S-1/A, S-1, D.
EX-99.1 21 ea025693901ex99-1_exxel.htm CONSENT OF NITIN KAUSHAL AS DIRECTOR NOMINEE Exhibit 99.1 CONSENT TO BE NAMED AS DIRECTOR NOMINEE In connection with the filing by Exxel Pharma Inc, a Colorado corporation (the “Company”) of its Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended, (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to be named as a nominee to the board of director…
Read attachment ↗EX-99.2 22 ea025693901ex99-2_exxel.htm CONSENT OF ANUJ MEDHOK AS DIRECTOR NOMINEE Exhibit 99.2 CONSENT TO BE NAMED AS DIRECTOR NOMINEE In connection with the filing by Exxel Pharma Inc, a Colorado corporation (the “Company”) of its Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended, (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to be named as a nominee to the board of directors …
Read attachment ↗